Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TRPM8 | Q7Z2W7 | 4/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.35 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10700915 | 0.89 | KCNA5 (0.50) | KCNA5ALDH1A1LMNATRPM8TRPA1 | |
| SCHEMBL8498802 | 0.83 | KCNA5 (0.46) | KCNA5ALDH1A1LMNATRPM8TRPA1 | |
| SCHEMBL5824341 | 0.81 | OPRM1 (0.47) | KCNA5ALDH1A1LMNATRPM8TRPA1 | |
| SCHEMBL9792242 | 0.81 | KCNA5 (0.42) | KCNA5ALDH1A1LMNATRPM8TRPA1 | |
| SCHEMBL2392586 | 0.79 | OPRM1 (0.45) | KCNA5ALDH1A1LMNATRPM8TRPA1 | |
| SCHEMBL7540738 | 0.79 | KDM1A (0.49) | KCNA5ALDH1A1LMNATRPM8TRPA1 | |
| SCHEMBL17847282 | 0.79 | HTR2C (0.46) | KCNA5ALDH1A1LMNATRPM8HPGD | |
| SCHEMBL28635808 | 0.79 | TRPM8 (0.46) | KCNA5ALDH1A1LMNATRPM8TRPA1 | |
| SCHEMBL30506638 | 0.79 | HTR2C (0.46) | KCNA5ALDH1A1LMNATRPM8HPGD | |
| SCHEMBL3639819 | 0.77 | KCNA5 (0.53) | KCNA5ALDH1A1LMNATRPM8TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0831871-A4 | RELAXIN-LIKE FACTOR AND METHODS AND USES THEREOF | CONNECTIVE THERAPEUTICS INC (US) | 1999-03-03 | — | — | EP | disclosed |
| EP-0831871-A1 | RELAXIN-LIKE FACTOR AND METHODS AND USES THEREOF | CONNECTIVE THERAPEUTICS, INC. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996040186-A1 | RELAXIN-LIKE FACTOR AND METHODS AND USES THEREOF | CONNECTIVE THERAPEUTICS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0462229-A4 | CHEMICALLY MODIFIED CD4 PEPTIDE FRAGMENTS HAVING ANTI-RETROVIRAL PROPERTIES | — | 1992-03-11 | — | — | EP | disclosed |
| EP-0462229-A1 | CHEMICALLY MODIFIED CD4 PEPTIDE FRAGMENTS HAVING ANTI-RETROVIRAL PROPERTIES | GENELABS, INCORPORATED (US) | 1991-12-27 | — | — | EP | disclosed |
| WO-1990013562-A1 | CHEMICALLY MODIFIED CD4 PEPTIDE FRAGMENTS HAVING ANTI-RETROVIRAL PROPERTIES | GENELABS INCORPORATED (US) | 1990-11-15 | — | — | WO | disclosed |